FDA Proved Lansoprazole for Injection of Inhibiting Gastric Acid

Model NO.: DAWALFI0001 Usage Mode: For external use State: Solid Type: Biological Products Name: Lansoprazole for Injection MOQ: 1 Box Trademark: GUYENNE Origin: France Application: Internal Medicine Suitable for: Elderly, Children, Adult Shape: Powder Pharmaceutical Technology: Chemical Synthesis Administration Route: I.V OEM: Acceptable Specification: 30mg FDA Proved Lansoprazole For Injection Of Inhibiting Gastric Acid
 

Specification	30mg
Package	10vials/tray/box

Lansoprazole  is a proton-pump inhibitor (PPI) which inhibits the stomach's production of gastric acids.
It is a proton-pump inhibitor (PPI) in the same pharmacologic class as omeprazole. Lansoprazole has been marketed for many years and is one of several PPIs available. It is a racemic 1:1 mixture of the enantiomers dexlansoprazole (Dexilant, formerly named Kapidex) and levolansoprazole. Dexlansoprazole is an enantiomerically pure active ingredient of a commercial drug as a result of the enantiomeric shift.
Lansoprazole's plasma elimination half-life (1.5 h) is not proportional to the duration of the drug's effects to the person (i.e. gastric acid suppression). and the effects of the drug last for over 24 hours after it has been used for a day or more. Lansoprazole, 30-mg administered nasogastrically, effectively controls intragastric pH and is an alternative to intravenous pantoprazole in patients who are unable to swallow solid-dose formulations.

Indications
Lansoprazole is indicated for treatment of:
Ulcers of the stomach and duodenum, and NSAID-induced ulcers
 
Gastroesophageal reflux disease
Zollinger-Ellison syndrome

Side effects
Common: diarrhea, abdominal pain
Infrequent: dry mouth, insomnia, drowsiness, blurred vision, rash, pruritus
Rarely and very rarely: taste disturbance, liver dysfunction, peripheral oedema, hypersensitivity reactions (including bronchospasm, urinary, angioedema, anaphylaxis), photosensitivity, fever, sweating, depression, interstitial nephritis, blood disorders (including leukopenia, leukocytosis, pancytopenia, thrombocytopenia), arthralgia, myalgia, skin reactions including (erythroderma Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous eruption)
PPIs may be associated with a greater risk of hip fractures and Clostridium difficile-associated diarrhea.

Contact us if you need more details on Gastric Ulcer. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Prevacid、Reflux Esophagitis. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Gastro-Intestinals Drug